Zheng C, Hu X, Zhao L, Hu M, & Gao F. (2017). Clinical and pharmacological hallmarks of rifapentine’s use in diabetes patients with active and latent tuberculosis: Do we know enough? Dove Medical Press.
Παραπομπή σε μορφή Chicago (17η εκδ.)Zheng C, Hu X, Zhao L, Hu M, και Gao F. Clinical and Pharmacological Hallmarks of Rifapentine’s Use in Diabetes Patients with Active and Latent Tuberculosis: Do We Know Enough? Dove Medical Press, 2017.
Παραπομπή σε μορφή MLA (9th εκδ.)Zheng C, et al. Clinical and Pharmacological Hallmarks of Rifapentine’s Use in Diabetes Patients with Active and Latent Tuberculosis: Do We Know Enough? Dove Medical Press, 2017.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.